We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TXRH:NASDAQTexas Roadhouse, Inc. Analysis

Data as of 2026-05-28 - not real-time

$181.49

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Texas Roadhouse delivered a strong first‑quarter, with revenue topping $1.6 billion and comparable‑sales up 7.1%, propelling the stock 12.9% higher over the past month. The company’s 12.8% year‑over‑year revenue growth, 6.85% profit margin and a solid 28.9% ROE underscore robust operating performance, while the dividend payout ratio of 44.5% suggests the 1.65% yield remains sustainable. Technically, the share price of $181.49 sits above the 20‑day (≈$172) and 50‑day (≈$167) moving averages, the RSI sits at a healthy 63, and the MACD histogram is positive, indicating continued bullish momentum, though volume is trending down and the price is nearing the $185 resistance level.
Valuation metrics tell a more cautious story: a trailing P/E of 29 and a forward P/E of 23.8 place the stock at a premium to peers, and a discounted cash‑flow fair‑value estimate of roughly $52 per share implies the market is pricing in significant growth expectations. The company carries a high debt‑to‑equity ratio (~68%) and a net‑debt position that exceeds cash balances, adding balance‑sheet risk, while the consumer‑cyclical nature of the restaurant sector introduces medium‑level sector risk. Overall, the stock appears slightly overvalued despite strong earnings momentum and a sustainable dividend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price approaching $185 resistance with decreasing volume
  • Bullish technical indicators (MACD, RSI, SMAs)
  • High valuation relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong Q1 earnings beat and revenue growth
  • Analyst target median price of $196 indicating upside
  • Sustainable dividend and solid ROE

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Durable brand and franchise model in a consumer‑cyclical sector
  • Elevated debt levels that could limit flexibility
  • Continued dividend payments supporting shareholder yield

Key Metrics & Analysis

Financial Health

Revenue Growth12.80%
Profit Margin6.85%
P/E Ratio29.0
ROE28.92%
ROA8.99%
Debt/Equity68.53
P/B Ratio7.9
Op. Cash Flow$751.4M
Free Cash Flow$190.2M

Technical Analysis

TrendNeutral
RSI63.0
Support$153.83
Resistance$185.10
MA 20$171.90
MA 50$167.12
MA 200$171.92
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value$52.22
Target Price$196.67
Upside/Downside8.36%
GradeOvervalued
TypeBlend
Dividend Yield1.65%

Risk Assessment

Beta0.61
Volatility42.05%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.